CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 393232-393293 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","sourcedb":"CORD-19","sourceid":"3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03","text":"His twostep TST resulted negative and he began on adalimumab.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2978","span":{"begin":0,"end":61},"obj":"Sentence"},{"id":"T80538","span":{"begin":0,"end":61},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T2978","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T80538","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T22","span":{"begin":0,"end":61},"obj":"Sentence"}],"attributes":[{"subj":"T22","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1290","span":{"begin":38,"end":40},"obj":"Disease"},{"id":"T46887","span":{"begin":38,"end":40},"obj":"Disease"}],"attributes":[{"id":"A1290","pred":"mondo_id","subj":"T1290","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"id":"A81107","pred":"mondo_id","subj":"T46887","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"subj":"T1290","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T46887","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#e8ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#d693ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecbc"}]}]}}